European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors

医学 后肾 肾上腺皮质癌 嗜铬细胞瘤 偶发瘤 恶性肿瘤 振作起来 内科学 肾上腺皮质腺瘤 腺瘤 放射科
作者
Martin Faßnacht,Stylianos Tsagarakis,Massimo Terzolo,Antoine Tabarin,Anju Sahdev,John D C Newell-Price,Iris C. M. Pelsma,Ljiljana Marina,Kerstin Lorenz,Irina Bancos,Wiebke Arlt,Olaf M. Dekkers
出处
期刊:European journal of endocrinology [Oxford University Press]
卷期号:189 (1): G1-G42 被引量:983
标识
DOI:10.1093/ejendo/lvad066
摘要

Adrenal incidentalomas are adrenal masses detected on imaging performed for reasons other than suspected adrenal disease. In most cases, adrenal incidentalomas are nonfunctioning adrenocortical adenomas but may also require therapeutic intervention including that for adrenocortical carcinoma, pheochromocytoma, hormone-producing adenoma, or metastases. Here, we provide a revision of the first international, interdisciplinary guidelines on incidentalomas. We followed the Grading of Recommendations Assessment, Development and Evaluation system and updated systematic reviews on 4 predefined clinical questions crucial for the management of incidentalomas: (1) How to assess risk of malignancy?; (2) How to define and manage mild autonomous cortisol secretion?; (3) Who should have surgical treatment and how should it be performed?; and (4) What follow-up is indicated if the adrenal incidentaloma is not surgically removed? Selected Recommendations: (1) Each adrenal mass requires dedicated adrenal imaging. Recent advances now allow discrimination between risk categories: Homogeneous lesions with Hounsfield unit (HU) ≤ 10 on unenhanced CT are benign and do not require any additional imaging independent of size. All other patients should be discussed in a multidisciplinary expert meeting, but only lesions >4 cm that are inhomogeneous or have HU >20 have sufficiently high risk of malignancy that surgery will be the usual management of choice. (2) Every patient needs a thorough clinical and endocrine work-up to exclude hormone excess including the measurement of plasma or urinary metanephrines and a 1-mg overnight dexamethasone suppression test (applying a cutoff value of serum cortisol ≤50 nmol/L [≤1.8 µg/dL]). Recent studies have provided evidence that most patients without clinical signs of overt Cushing's syndrome but serum cortisol levels post dexamethasone >50 nmol/L (>1.8 µg/dL) harbor increased risk of morbidity and mortality. For this condition, we propose the term "mild autonomous cortisol secretion" (MACS). (3) All patients with MACS should be screened for potential cortisol-related comorbidities that are potentially attributably to cortisol (eg, hypertension and type 2 diabetes mellitus), to ensure these are appropriately treated. (4) In patients with MACS who also have relevant comorbidities surgical treatment should be considered in an individualized approach. (5) The appropriateness of surgical intervention should be guided by the likelihood of malignancy, the presence and degree of hormone excess, age, general health, and patient preference. We provide guidance on which surgical approach should be considered for adrenal masses with radiological findings suspicious of malignancy. (6) Surgery is not usually indicated in patients with an asymptomatic, nonfunctioning unilateral adrenal mass and obvious benign features on imaging studies. Furthermore, we offer recommendations for the follow-up of nonoperated patients, management of patients with bilateral incidentalomas, for patients with extra-adrenal malignancy and adrenal masses, and for young and elderly patients with adrenal incidentalomas. Finally, we suggest 10 important research questions for the future.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Young离子完成签到 ,获得积分10
1秒前
zyy发布了新的文献求助10
1秒前
why完成签到,获得积分10
1秒前
2秒前
Lee发布了新的文献求助10
2秒前
zsg发布了新的文献求助10
3秒前
Sicily完成签到,获得积分10
3秒前
JamesPei的应助被张会采纳,获得10
3秒前
4秒前
5秒前
5秒前
5秒前
Sicily发布了新的文献求助10
6秒前
zhoushuai发布了新的文献求助10
6秒前
负责念梦完成签到,获得积分10
6秒前
王德荣发布了新的文献求助10
6秒前
英俊的铭的应助被缓慢半山采纳,获得10
6秒前
lyn完成签到,获得积分10
6秒前
11111完成签到,获得积分10
7秒前
forever完成签到,获得积分10
7秒前
或大或小发布了新的文献求助10
7秒前
8秒前
玊尔玉完成签到,获得积分20
9秒前
lyn发布了新的文献求助10
9秒前
9秒前
9秒前
灵运完成签到,获得积分10
9秒前
pray完成签到,获得积分10
9秒前
10秒前
xixihaha发布了新的文献求助10
10秒前
情怀的应助被zyy采纳,获得30
10秒前
Nana完成签到,获得积分10
11秒前
无花果的应助被xiaobai采纳,获得10
11秒前
11秒前
鲤鱼鑫磊发布了新的文献求助10
12秒前
SSSYYY完成签到,获得积分10
13秒前
dde发布了新的文献求助10
13秒前
13秒前
ZEcholy完成签到,获得积分10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187362
求助须知:如何正确求助?哪些是违规求助? 9575478
关于积分的说明 21841431
捐赠科研通 7785067
什么是DOI,文献DOI怎么找? 3434943
关于科研通互助平台的介绍 2559401
邀请新用户注册赠送积分活动 2481820